BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15579795)

  • 1. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism.
    Daelemans C; Smits G; de Maertelaer V; Costagliola S; Englert Y; Vassart G; Delbaere A
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6310-5. PubMed ID: 15579795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symposium: Update on prediction and management of OHSS. Genetics of ovarian hyperstimulation syndrome.
    Rizk B
    Reprod Biomed Online; 2009 Jul; 19(1):14-27. PubMed ID: 19573286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation.
    Nenonen HA; Lindgren IA; Prahl AS; Trzybulska D; Kharraziha I; Hultén M; Giwercman YL; Henic E
    Pharmacogenet Genomics; 2019 Jul; 29(5):114-120. PubMed ID: 30829738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
    Huang X; Li L; Hong L; Zhou W; Shi H; Zhang H; Zhang Z; Sun X; Du J
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):577-83. PubMed ID: 25132286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome.
    Binder H; Dittrich R; Hager I; Müller A; Oeser S; Beckmann MW; Hamori M; Fasching PA; Strick R
    Reproduction; 2008 Jan; 135(1):107-16. PubMed ID: 18159088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exclusion of coding-region mutations in luteinizing hormone and follicle-stimulating hormone receptor genes as the cause of ovarian hyperstimulation syndrome.
    Kerkelä E; Skottman H; Friden B; Bjuresten K; Kere J; Hovatta O
    Fertil Steril; 2007 Mar; 87(3):603-6. PubMed ID: 17074323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous and iatrogenic ovarian hyperstimulation syndrome in the absence of FSHR mutations: a case report of two unexpected cases.
    Daolio J; Sperduti S; Casarini L; Falbo A; Materazzo C; Aguzzoli L; Villani MT
    BMC Med Genomics; 2023 Mar; 16(1):45. PubMed ID: 36882810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology.
    De Leener A; Montanelli L; Van Durme J; Chae H; Smits G; Vassart G; Costagliola S
    J Clin Endocrinol Metab; 2006 Feb; 91(2):555-62. PubMed ID: 16278261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of the FSH receptor: new insights into FSH physiology.
    Meduri G; Bachelot A; Cocca MP; Vasseur C; Rodien P; Kuttenn F; Touraine P; Misrahi M
    Mol Cell Endocrinol; 2008 Jan; 282(1-2):130-42. PubMed ID: 18248882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women.
    Achrekar SK; Modi DN; Desai SK; Mangoli VS; Mangoli RV; Mahale SD
    Fertil Steril; 2009 Feb; 91(2):432-9. PubMed ID: 18321487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two different entities of spontaneous ovarian hyperstimulation in a woman with FSH receptor mutation.
    Dieterich M; Bolz M; Reimer T; Costagliola S; Gerber B
    Reprod Biomed Online; 2010 Jun; 20(6):751-8. PubMed ID: 20378412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?
    Delbaere A; Smits G; Olatunbosun O; Pierson R; Vassart G; Costagliola S
    Hum Reprod; 2004 Mar; 19(3):486-9. PubMed ID: 14998941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian hyperstimulation syndrome in a spontaneous pregnancy with invasive mole.
    Wu X; Zhu J; Zhao A
    J Obstet Gynaecol Res; 2015 May; 41(5):817-22. PubMed ID: 25492410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome.
    Montanelli L; Delbaere A; Di Carlo C; Nappi C; Smits G; Vassart G; Costagliola S
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1255-8. PubMed ID: 15080154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome.
    Montanelli L; Delbaere A; Di Carlo C; Nappi C; Smits G; Vassart G; Costagliola S
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1255-8. PubMed ID: 15001619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of follicle-stimulating hormone receptor activating mutations in women with iatrogenic ovarian hyperstimulation syndrome.
    d'Alva CB; Serafini P; Motta E; Kohek MB; Latronico AC; Mendonca BB
    Fertil Steril; 2005 Jun; 83(6):1695-9. PubMed ID: 15950638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of follicle-stimulating hormone receptor (FSHR) -29 and Ser680Asn polymorphisms in IVF/ICSI.
    Paschalidou C; Anagnostou E; Mavrogianni D; Raouasnte R; Klimis N; Drakakis P; Loutradis D
    Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32114522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian hyperstimulation syndrome (OHSS) due to mutations in the follicle-stimulating hormone receptor.
    Rodien P; Beau I; Vasseur C
    Ann Endocrinol (Paris); 2010 May; 71(3):206-9. PubMed ID: 20362966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inferring biallelism of two FSH receptor mutations associated with spontaneous ovarian hyperstimulation syndrome by evaluating FSH, LH and HCG cross-activity.
    Lazzaretti C; Riccetti L; Sperduti S; Anzivino C; Brigante G; De Pascali F; Potì F; Rovei V; Restagno G; Mari C; Lussiana C; Benedetto C; Revelli A; Casarini L
    Reprod Biomed Online; 2019 May; 38(5):816-824. PubMed ID: 30910395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein 15 (BMP15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS).
    Morón FJ; de Castro F; Royo JL; Montoro L; Mira E; Sáez ME; Real LM; González A; Mañes S; Ruiz A
    Pharmacogenet Genomics; 2006 Jul; 16(7):485-95. PubMed ID: 16788381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.